Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-Dose ChAdOx1 nCoV-19 Vaccine in Viana
NCT05059106Phase 3Unknown
- Sponsor
- Universidade Federal do Espírito Santo
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Universidade Federal do Espírito Santo. Status: unknown.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05059106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059106.